The estimated Net Worth of Ventures Ix, L.P.Healthcare... is at least 11.5 百万$ dollars as of 5 February 2019. Ventures Healthcare owns over 571,428 units of Leap Therapeutics Inc stock worth over 11,481,107$ and over the last 7 years Ventures sold LPTX stock worth over 0$.
Ventures has made over 2 trades of the Leap Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Ventures bought 571,428 units of LPTX stock worth 999,999$ on 5 February 2019.
The largest trade Ventures's ever made was buying 1,057,769 units of Leap Therapeutics Inc stock on 14 November 2017 worth over 6,441,813$. On average, Ventures trades about 407,299 units every 112 days since 2017. As of 5 February 2019 Ventures still owns at least 4,144,804 units of Leap Therapeutics Inc stock.
You can see the complete history of Ventures Healthcare stock trades at the bottom of the page.
Over the last 8 years, insiders at Leap Therapeutics Inc have traded over 0$ worth of Leap Therapeutics Inc stock and bought 10,810,588 units worth 40,517,079$ . The most active insiders traders include Advisors Llcperceptive Life...、Christopher Mirabelli、Ltd. Bei Gene,. On average, Leap Therapeutics Inc executives and independent directors trade stock every 142 days with the average trade being worth of 1,990,710$. The most recent stock trade was executed by Christopher Mirabelli on 26 January 2024, trading 5,000 units of LPTX stock currently worth 13,850$.
leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via http://www.investors.leaptx.com.
Leap Therapeutics Inc executives and other stock owners filed with the SEC include: